Showing results (71-80 of 84) with videos related to

Sort By:
Pageof 9
Chinese Journal of Integrative Medicine|January 12, 2024
Pien Tze Huang Inhibits Proliferation of Colorectal Cancer Cells through Suppressing PNO1 Expression and Activating p53/p21 Signaling PathwayLiu-Jing Cao, Li-Ya Liu, You-Qin Chen, et al.
Bone Marrow Transplantation|April 13, 2021
Risk factors and outcomes of diffuse alveolar haemorrhage after allogeneic haematopoietic stem cell transplantationJin Wu, Hai-Xia Fu, Yun He, et al.
Chinese Medical Journal|September 14, 2020
Urodynamic assessment of bladder storage function after radical hysterectomy for cervical cancerTing-Ting Cao, Hong-Wu Wen, Yu-Nong Gao, et al.
Frontiers in Pharmacology|January 5, 2026
Rifapentine- and moxifloxacin-containing short-course regimens for mild spinal tuberculosis: study protocol for a multicenter, randomized, non-inferiority phase II clinical trialYue-E Wu, Jing Cao, Li Wang, et al.
Annals of Hematology|August 1, 2020
Comparison of different cytomegalovirus diseases following haploidentical hematopoietic stem cell transplantationXing-Ye Meng, Hai-Xia Fu, Xiao-Lu Zhu, et al.
British Journal of Haematology|April 29, 2023
Predicting short-term and long-term mortalities from sepsis in patients who receive allogeneic haematopoietic stem cell transplantationYe-Jun Wu, Hui-Xin Liu, Xiao-Lu Zhu, et al.
Blood Advances|November 13, 2019
Overexpression of WT1 and PRAME predicts poor outcomes of patients with myelodysplastic syndromes with thrombocytopeniaQiu-Sha Huang, Jing-Zhi Wang, Ya-Zhen Qin, et al.
Cancer Letters|April 8, 2026
Survival Benefit of Allogeneic HSCT in CMML patients During the Molecular Stratification EraRui Ma, Jin Zhang, Mei-Xiang Zhang, et al.
British Journal of Haematology|May 27, 2020
Development and validation of a prediction model (AHC) for early identification of refractory thrombotic thrombocytopenic purpura using nationally representative dataRuo-Yun Gui, Qiu-Sha Huang, Xuan Cai, et al.
American Journal of Hematology|July 9, 2024
Safety and efficacy of baricitinib in steroid-resistant or relapsed immune thrombocytopenia: An open-label pilot studyPeng Zhao, Zhuo-Yu An, Hai-Xia Fu, et al.
Pageof 9